Skip to main content

They Have Alzheimer’s. This Clinical Trial May Be a Last Hope.

By Commentary, In the News
Bob and Marlene Lippman in their home. “Bob had a very strong intellect,” Ms. Lippman said. “It is hard that that part of him is being attacked.”Credit...Jackie Molloy for The New York Times The single most consistent barrier to progress in Alzheimer’s disease treatment development is low rates of participation in research. To learn about clinical trials at UCI MIND, visit https://www.mind.uci.edu/research-studies/participate/. To enroll in the C2C Registry and give researchers permission to let you know about new studies for which you might be eligible, visit c2c.uci.edu.
Read More

Anti-Asian American Hate Crimes Bill

By Commentary, COVID-19, In the News
Contributed by Hye-Won (Grace) Shin, PhD UCI MIND stands against racism, hate and violence. We laud the US Senate overwhelmingly passing the anti-Asian American hate crime bill Thursday, April 22, 2021. We stand with our Asian American researchers, physician scientists, research participants, patients and their caregivers and our broader Asian community members. As we painfully witnessed, hate crimes, physical attacks and deplorable rhetoric against Asians across the United States have escalated. According to the research report by the Center for the Study of Hate & Extremism at California State University, San Bernardino, hate crimes targeting Asians in the first quarter…
Read More

UCI MIND investigators develop new “platform model” to study late-onset Alzheimer’s disease

By Commentary, In the News
Contributed by Stefania Forner, PhD Most cases of Alzheimer’s disease (AD) are late-onset and occur sporadically; however, the majority of AD animal models are based on rare genetic mutations, making them good models of the less common familial AD, which accounts for 1% of all cases. As treatments effective in these mouse models have proven ineffective in humans, there is a clear need to develop new models that better represent the more common, late-onset sporadic form of AD. With this in mind, my colleagues and I at UCI MIND used a different approach in a recent study published in Nature…
Read More

UCI MIND Annual Report 2020: Excellence through Adversity

By Commentary, COVID-19, In the News
UCI MIND Annual Report 2020: Excellence through Adversity Dear Friend of UCI MIND, The COVID-19 pandemic has impacted every facet of life, especially for families enduring Alzheimer’s disease and related dementias. In 2020 alone, deaths due to Alzheimer’s increased 16% in the United States. Caregivers were forced to adapt how they manage care and cope with burden, while many endured painful separation from loved ones. Researchers faced delays and challenges in continuing our work. Yet, the past year has further ignited in us an urgency to discover solutions for Alzheimer’s disease and related dementias and improve the lives of those…
Read More

Minorities Receive Less Timely Dementia Diagnoses Than Whites

By Carousel Slider, Commentary, In the News
CHINNAPONG/GETTY IMAGES An accompanying editorial in JAMA Neurology noted that the study apparently is the first to focus on disparities related to “time to diagnosis and comprehensiveness of evaluation” of dementia. Claudia Kawas, M.D., a , geriatric neurologist and researcher at the University of California, Irvine, and other authors of the editorial … point to the need for more diversity in dementia research — particularly as the aging U.S. population grows more diverse.
Read More

Join us for UCI Giving Day on Wednesday, April 28!

By Commentary, Community Events
COVID-19 has introduced tremendous uncertainty into our lives. It has made life challenging for many, none more than families facing Alzheimer’s disease and related dementias. Yet, one certainty remains – brain diseases will devastate our increasingly older population…unless researchers find solutions. UCI MIND remains focused on these efforts. To support the scientists, students, and programs across our great university, donate to dementia research on #UCIGivingDay coming up on Wednesday, April 28th. Help us rise to the challenge and unlock a $2,500 gift in support of Alzheimer's research from Belmont Village by being one of the first 50 donors to UCI…
Read More